Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.

Cerrato, F

Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes. [electronic resource] - British journal of pharmacology Mar 2015 - 1379-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-5381

10.1111/bph.13016 doi


Cells, Cultured
Dose-Response Relationship, Drug
Down-Regulation--drug effects
Hep G2 Cells
Hepatocytes--drug effects
Humans
Lipoproteins, LDL--chemistry
Lovastatin--chemistry
Lymphocytes--cytology
Male
Raloxifene Hydrochloride--chemistry
Receptors, LDL--metabolism
Selective Estrogen Receptor Modulators--chemistry
Structure-Activity Relationship
Tamoxifen--chemistry
Toremifene--chemistry